CBD Capsules Reduced Seizures in Epileptic Children

Health and wellbeing company Satipharm has completed the second phase of their clinical trial into the effects of CBD on seizure frequency. The wholly-owned subsidiary of Canadian Cannabis company, HarvestOne, discovered an overall reduction in seizures among 16 paediatric patients.

Clinicians observed an average seizure reduction of 73.4%, with two patients becoming seizure-free in five weeks. A further seven patients experienced a reduction of more than 50%.

Phase 1 of the trial focused on the efficacy of Satipharm’s CBD Gelpell® capsule. The capsule contains a 50mg dose of full-spectrum Hemp extract CBD in a large number of soluble gelatine beads. These beads are then placed inside a hard gastro-resistant capsule, to ensure the release of the CBD in the small intestine.

Source: Satipharm

The evidence collected from phase 1 of the trial proved that the Gelpell capsules increased the bioavailability of the CBD. This is because

... read more at: https://canex.co.uk/cbd-capsules-reduced-seizures-in-epileptic-children/


Leave a Reply